The AAAAI annual meeting is a hub of scientific breakthroughs and new treatments. Here are the highlights from the 2015 conference.
In trials, Viaskin Peanut allowed some participants to tolerate 10 times more peanut protein than at the outset.
Chance of developing peanut allergy reduced 70 to 80 percent in high-risk babies. New guidelines expected.
Emergency auto-injectors were used in more than 900 cases of anaphylaxis in U.S. schools last academic year.
The FDA is advising people who are highly allergic to peanuts to consider avoiding products that contain ground cumin or cumin powder.
A father shares the story of his 3-year-old son’s terrifying severe allergic reaction, and why it changed everything.
Researchers in Australia have introduced a game-changing idea in the hunt for a peanut allergy cure. They combined a large daily dose of specific probiotics with oral immunotherapy to find out whether this would effectively treat peanut allergy.